Hereditary Endocrine Tumours: Current State-Of-The-Art and Research Opportunities: the State of Science in Medullary Thyroid Carcinoma: Current Challenges and Unmet Needs

Dadu, R.; Bagheri-Yarmand, R.; Ringel, M.D.; Grubbs, E.G.; Zafereo, M.; Cote, G.; Gagel, R.F.; Robinson, B.G.; Shaw, K.R.; Hu, M.I.

Endocrine-Related Cancer 27(8): T27-T39

2020


ISSN/ISBN: 1479-6821
PMID: 32580150
Accession: 071851110

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
The 16th International Multiple Endocrine Neoplasia Workshop (MEN2019) held in Houston, TX, USA, focused on emerging topics in the pathogenesis and therapy of malignant endocrine tumors associated with MEN syndromes. With MEN-2 syndromes, the most common malignancy is medullary thyroid carcinoma (MTC). In the spirit of the original MEN meeting workshop model, the conference included didactic lectures and interactive working groups of clinicians and researchers focused on the state of science in MTC and ongoing challenges or unmet needs in the understanding of MTC and to develop strategies to address these issues.